Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.57 is 62% above its 5-year average of -1.52, near the high end of its 5-year range (-2.17–-0.57).
28.30% above its 12-month average of -0.80.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.57
EARNINGS PER SHARE (EPS) AVG TTM
-0.80
EARNINGS PER SHARE (EPS) AVG 3Y
-1.19
EARNINGS PER SHARE (EPS) AVG 5Y
-1.52
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.30%
CURRENT VS 3Y AVG
+52.20%
CURRENT VS 5Y AVG
+62.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NeuroPace, Inc.
Market Cap
$446.29M
Earnings Per Share (EPS)
-0.57
TTM Avg
-0.80
3Y Avg
-1.19
5Y Avg
-1.52
Market Cap
$444.98M
Earnings Per Share (EPS)
-0.72
TTM Avg
-0.65
3Y Avg
-0.60
5Y Avg
-0.64
Market Cap
$444.69M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.30
3Y Avg
-0.53
5Y Avg
-0.29
Market Cap
$441.97M
Earnings Per Share (EPS)
-2.45
TTM Avg
-1.70
3Y Avg
-1.35
5Y Avg
-1.20
Market Cap
$435.38M
Earnings Per Share (EPS)
0.55
TTM Avg
-3.62
3Y Avg
-10.86
5Y Avg
-15.74
Market Cap
$432.39M
Earnings Per Share (EPS)
-4.57
TTM Avg
-3.99
3Y Avg
-6.52
5Y Avg
-18.52
Market Cap
$430.17M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
Market Cap
$428.59M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroPace, Inc. (NPCE) | $446.29M | -0.57 | -0.80 | -1.19 | -1.52 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $444.98M | -0.72 | -0.65 | -0.60 | -0.64 |
| Ovid Therapeutics Inc. (OVID)vs › | $444.69M | -0.48 | -0.30 | -0.53 | -0.29 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $441.97M | -2.45 | -1.70 | -1.35 | -1.20 |
| NRC Health (NRC)vs › | $457.04M | 0.25 | 0.79 | 1.03 | 1.18 |
| Assembly Biosciences, Inc. (ASMB)vs › | $435.38M | 0.55 | -3.62 | -10.86 | -15.74 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $432.39M | -4.57 | -3.99 | -6.52 | -18.52 |
| Editas Medicine, Inc. (EDIT)vs › | $430.17M | -0.75 | -2.34 | -2.48 | -2.46 |
| NeoGenomics, Inc. (NEO)vs › | $428.59M | -1.98 | -3.65 | -4.15 | -2.79 |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | -0.56 | -0.89 | -1.18 | -1.13 |
Trailing EPS (TTM)
$-0.57
Forward EPS (Est.)
$-0.58
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.66 |
| 2024-12-31 | -0.93 |
| 2023-12-31 | -1.27 |
| 2022-12-31 | -1.91 |
| 2021-12-31 | -2.17 |
| 2020-12-31 | -2.17 |
| 2019-12-31 | -2.70 |
